One function of skin microbiota is to resist colonization and infection by external microorganisms. We sought to detect whether the structure of the hand microbiota of 34 healthcare workers (HCW) in a surgical intensive care unit mediates or modifies the relationship between demographic and behavioral factors and potential pathogen carriage on hands after accounting for pathogen exposure. We used a taxonomic screen (16S rRNA) to characterize the bacterial community, and qPCR to detect presence of Staphylococcus aureus, Enterococcus spp., methicillin-resistant Staphylococcus aureus (MRSA), and Candida albicans on their dominant hands. Hands were sampled weekly over a 3-week period. Age, hand hygiene, and work shift were significantly associated with potential pathogen carriage and the associations were pathogen dependent. Additionally, the overall hand microbiota structure was associated with the carriage of potential pathogens. Hand microbiota community structure may act as a biomarker of pathogen carriage, and modifying that structure may potentially limit pathogen carriage among HCW.
References
[1]
Cho, I.; Blaser, M. The human microbiome: At the interface of health and disease. Nature 2012, 13, 260–270.
[2]
Kinross, J.; Darzi, A.; Nicholson, J. Gut microbiome-host interactions in health and disease. Genome Med. 2011, 3, 14, doi:10.1186/gm228.
[3]
Petrof, E.; Gloor, G.; Vanner, S.; Weese, S.; Carter, D.; Daigneault, M.; Brown, E.; Schroeter, K.; Allen-Vercoe, E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome 2013, doi:10.1186/2049-2618-1-3.
[4]
McBride, M.; Duncan, W.; Knox, J. The environment and the microbial ecology of human skin. Appl. Environ. Microbiol. 1977, 33, 603–608.
[5]
Selwyn, S. Natural antibiosis among skin bacteria as a primary defence against infection. Brit. J. Dermatol. 1975, 93, 487–493, doi:10.1111/j.1365-2133.1975.tb02241.x.
[6]
Fredricks, D. Microbial Ecology of Human Skin in Health and Disease. J. Investig. Dermatol. Symp. Proc. 2001, 6, 167–169, doi:10.1046/j.0022-202x.2001.00039.x.
[7]
Van Belkum, A.; Melles, D.; Nouwen, J.; van Leeuwen, W.; van Wamel, W.; Vos, M.; Wertheim, H.; Verbrugh, H. Co-evolutionary aspects of human colonization and infection by Staphylococcus aureus. Infect. Genet. Evol. 2009, 9, 32–47, doi:10.1016/j.meegid.2008.09.012.
[8]
Horn, P.; Schouenborg, P.; Brandslund, I. Quantification of Staphylococcus aureus and Staphylococcus epidermidis on the hands of health-care workers using a real-time polymerase chain reaction method. Scand. J. Clin. Lab. Invest. 2007, 67, 165–177, doi:10.1080/00365510600996539.
[9]
Hayden, M. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin. Infect. Dis. 2001, 31, 1058–1065, doi:10.1086/318126.
[10]
Creamer, E.; Dorrian, S.; Dolan, A.; Sherlock, O.; Fitzgerald-Hughes, D.; Thomas, T.; Walsh, J.; Shore, A.; Sullivan, D.; Kinnevey, P.; et al. When are the hands of healthcare workers positive for methicillin-resistant Staphylococcus aureus? J. Hosp. Infect. 2010, 75, 107–111, doi:10.1016/j.jhin.2009.12.005.
[11]
Khan, Z.; Chandy, R.; Metwali, K. Candida albicans strain carriage in patients and nursing staff of an intensive care unit: A study of morphotypes and resistotypes. Mycoses 2003, 46, 479–486, doi:10.1046/j.0933-7407.2003.00929.x.
[12]
Boyce, J.; Pittet, D. Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm. Rep. 2002, 51, 1–45.
[13]
The WHO Guidelines on Hand Hygiene in Health Care. 2009. Available online: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf (accessed on 9 October 2013).
[14]
Rosenthal, M.; Goldberg, D.; Aiello, A.; Larson, E.; Foxman, B. Skin microbiota: Microbial community structure and its potential association with health and disease. Infect. Genet. Evol. 2011, 11, 839–848, doi:10.1016/j.meegid.2011.03.022.
[15]
Larson, E.; Hughes, A.; Pyrek, J.; Sparks, S.; Cagatay, E.; Bartkus, J. Changes in bacterial flora associated with skin damage on hands of health care personnel. Am. J. Infect. Control 1988, 26, 513–521.
[16]
Larson, E.; Butz, A.; Gullette, D.; Laughon, B. Alcohol for surgical scrubbing? Infect. Control Hosp. Epidemiol. 1990, 11, 139–143.
[17]
Larson, E.; Friedman, C.; Cohran, J.; Treston-Aurand, J.; Green, S. Prevalence and correlates of skin damage on the hands of nurses. Heart Lung 1997, 26, 404–412, doi:10.1016/S0147-9563(97)90027-3.
[18]
Berg, M. Evaluation of a questionnaire used in dermatological epidemiology. Discrepancy between self-reported symptoms and objective signs. Acta Derm. Venereol. Suppl. (Stockh.) 1991, 156, 13–17.
[19]
Simion, F.; Rhein, L.; Morrison, B.; Scala, D.; Salko, K.; Kligman, A. Self perceived sensory responses to soap and synthetic detergent bars correlate with clinical signs of irritation. J. Am. Acad. Dermatol. 1993, 22, 288–293.
[20]
Smit, H.; Coenraads, P.; Lavrijsen, A.; Nater, J. Evaluation of a self administered questionnaire on hand dermatitis. Contact Dermatitis 1992, 26, 11–16, doi:10.1111/j.1600-0536.1992.tb00861.x.
[21]
Farage, M.; Maibach, H.; Andersen, K.; Lachapelle, J.; Kern, P.; Ryan, C.; Ely, J.; Kanti, A. Historical perspective on the use of visual grading scales in evaluating skin irritation and sensitization. Contact Dermatitis 2011, 65, 65–75, doi:10.1111/j.1600-0536.2011.01912.x.
[22]
Hummelen, R.; Fernandes, A.; Macklaim, J.; Dickson, R.; Changalucha, J.; Gloor, G.; Reid, G. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010, 5, e12078.
[23]
Hidron, A.; Edwards, J.; Patel, J.; Horan, T.; Sievert, D.; Pollock, D.; Fridkin, S. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol. 2008, 29, 996–1011, doi:10.1086/591861.
[24]
Brakstad, O.; Aasbakk, K.; Maeland, J. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 1992, 30, 1654–1660.
[25]
Cuny, C.; Witte, W. PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfX. Clin. Microbiol. Infect. 2005, 11, 834–837, doi:10.1111/j.1469-0691.2005.01236.x.
[26]
Rinttil？, T.; Kassinen, A.; Malinen, E.; Krogius, L.; Palva, A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 2004, 97, 1166–1177, doi:10.1111/j.1365-2672.2004.02409.x.
[27]
Srinivasan, U.; Ponnaluri, S.; Villareal, L.; Gillespie, B.; Wen, A.; Miles, A.; Bucholz, B.; Marrs, C.; Iyer, R.; Misra, D.; et al. Gram stains: A resource for retrospective analysis of bacterial pathogens in clinical studies. PLoS One 2012, 7, e42898, doi:10.1371/journal.pone.0042898.
[28]
West, B.; Welch, K.; Galecki, A. Linear Mixed Models: A Practical Guide Using Statistical Software, 1st ed. ed.; Chapman Hall/CRC Press: Boca Raton, FL, USA, 2006; pp. 41–43.
[29]
Rosenthal, M.; Aiello, A.; Chenoweth, C.; Goldberg, D.; Larson, E.; Gloor, G.; Foxman, B. Impact of technical sources of variation on the hand microbiome dynamics of healthcare workers. PLoS ONE. submitted .
[30]
Kamada, N.; Seo, S.; Chen, G.; Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nature Immunol. 2013, 13, 321–335.
[31]
Tlaskalová-Hogenová, H.; ？tepánková, R.; Hudcovic, T.; Tucková, L.; Cukrowska, B.; Lodinová-？ádn？ková, R.; Kozáková, H.; Rossmanna, P.; Bártová, J.; Sokol, D.; et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 2004, 93, 97–108, doi:10.1016/j.imlet.2004.02.005.
